Sygnature is exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1

Join Drug Discovery 2016 – Uniting 1000 Global Delegates and 50 Renowned Speakers for Advancements in Drug Research

Elevate your understanding of cutting-edge drug research at Drug Discovery 2016, where an international assembly of 1000 esteemed delegates and 50 distinguished thought leaders from both academia and industry will converge to delve into crucial facets of drug discovery.

Key Scientific Discourses:

  1. Revolutionary Strides in Chemistry Innovations
  2. Exploring Oncology & Immunology Frontiers
  3. Advancements in Predictive & Translational Models
  4. Breakthroughs in Assay Development, Screening & Emerging Technologies
  5. Navigating Closer to Patient-Centric Approaches – Cells & Genes in Therapy & Diagnostics
  6. Pioneering Target Identification & Validation Strategies

Distinguished Plenary Keynotes:

  1. Professor Chas Bountra
    • Leading Scientist (SGC)
    • Translational Medicine Professor, University of Oxford
  2. Professor Munir Pirmohamed
    • David Weatherall Chair in Medicine
    • Royal Liverpool University Hospital
  3. Professor Dame Carol Robinson OBE
    • Esteemed Chemistry Professor
    • University of Oxford

Mark your calendar and be a part of this exceptional event, designed to illuminate the forefront of drug discovery. Secure your place today to amplify your knowledge and professional network.

Latest News

View All

Sygnature Discovery Receives EcoVadis Award For Sustainable…

Sygnature Discovery goes for global industry recognition…

First patients dosed in Phase 1a clinical…

Sygnature Discovery Appoints Industry Leaders To Board…